Lablog4-70:Albumin-based strategies to effectively prolong the circulation half-life of small immunomodulatory payloads in cancer therapy

, ,

Authors

Sara Linciano, Emilia Vigolo, Antonio Rosato, Yoichi Kumada, Alessandro Angelini

First author

Sara Linciano

Corresponding author

Alessandro Angeilni

Publication Style

Journal name Current Opinion in Biotechnology

Year  

Volume, issue, pages

90, 103218

Abstract

Small immunomodulatory payloads (IMMs) such as peptide vaccines and cytokines have the capability to activate and boost the immune response against cancer. However, their clinical use has often been hindered by their poor stability and short circulating half-lives. To enhance the pharmacokinetic properties of small IMMs and promote their trafficking and accumulation in lymphatic and tumor tissues, a large variety of strategies have been developed. One of the most successful relies on the use of serum albumin (SA), the most abundant protein in the circulatory and lymphatic system. Here, we report a comparative analysis of the different covalent and noncovalent SA-based strategies applied so far to improve the efficacy of small IMMs in cancer therapy.

DOI https://doi.org/10.1016/j.copbio.2024.103218